US Stem Cell Inc (USRM)

[BeamMeUpScotty]

This is important and I've posted this before, so here you go again. In AD*MD when they didn't get their FDA approval, they were told on a Wednesday, and didn't put out news till after hours on the Friday of that week.

Wednesday, Thursday and Friday of that week saw a systematic steady uniform decline in the share price of about 25% a day. The only reason the share price would have started falling was because the CEO was telling his friends and family to get out before he put out the 8k crashing the share price. It dropped by 90% the following Monday at open after already having seeing three days of declines.

In the reverse, if USRM had gotten RMAT approval, I'd expect them to be calling friends and family telling them to get in as it would be virtually certain that the share price would rise substantially - if - they get the RMAT approval.

I'm not seeing that steadily rising trading pattern here.

Lets be honest, to ourselves, the OTC is like a sieve. We all know that just about every stock seems to start moving upwards or downwards before good or bad news hits the market. As they say it is the nature of the beast!

This moved up after a group bought in is my guess and is now once again trading in a sideways/holding/channel pattern.

Call it what you will but I'm not seeing any large volume surges or spikes or big buys that suggest to me that they got RMAT approval.

My honest guess is that the FDA wants to see more recent data which is why they reinstated the trial.

I'll happily admit it if I'm wrong but you can see both scenarios very nicely in this post based on my observations over several years.

I don't see either of those scenarios playing out here.